Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-02-16
1990-04-24
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514299, 514305, 514413, 514414, 514409, 540543, 540602, 546 15, 546112, 546133, 548409, 548411, A61K 31395, C07D21300, C07D22102, C07D45302
Patent
active
049201271
ABSTRACT:
Compounds of formula (I), or a pharmaceutically acceptable salt thereof: ##STR1## wherein L is NH or O;
REFERENCES:
J. Nilsson et al., "Some Quinnolidine Derivatives with Potential Antimalarial Activity", ACTA Pharmaceutica Suecica, 5, pp. 71-76 (1968).
Joiner Karen A.
King Francis D.
Barr David K.
Beecham Group p.l.c.
Haley, Jr. James F.
Lee Mary C.
Richter J.
LandOfFree
Substituted indoles and their use as 5-HT.sub.3 receptor antagon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted indoles and their use as 5-HT.sub.3 receptor antagon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted indoles and their use as 5-HT.sub.3 receptor antagon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-34943